← Other glucose-lowering × glycemic control

TrialCirculation2017

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).

Mikhail Kosiborod et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 622 people · 2017

Not counted

Probably lowered glycemic control

−39%−49% to −27%

Bigger than 4 in 10 for glycemic control

As reported

HR 0.61, 95% CI 0.51–0.73

One number in the abstract

the abstract, start to end

… with lower rates of HHF (hazard ratio, 0.61; 95% confidence interval, …

← favours treatmentfavours comparator →
could be chance
Glycemic control
HR 0.610.51–0.73
SGLT2 inhibitorsOther glucose-loweringGlycemic control
1 / 3

362 papers cite itlatest 60 shown

2017
…
2020
2021
2022
2024
2025
2026
this paperpooled ittrialcites it

2 trials

NCT06286878phase 2/phase 380 enrolled2021NCT0299361499,999 enrolled2017
Full record →Abstract, authors, funding and every citing paper · PMID 28522450